ACST Acasti Pharma Inc.

Healthcare [ 3/11 ] | Biotechnology [ 34/154 ]

CA | NASDAQ | Stock

Price: $0.685

Decreased by -2.14%
Dollar Volume: 124.92 K
ADR%: 8.87
Earnings Report Date (estimate): Feb 13, 23 (-0.11)

Market Cap.: 30.56 M
Shares Float: 35.62 M
Shares Outstanding: 44.61 M

Beta: 1.10
Price / Earnings: -1.50
BPR: 34.45

20D Range: 0.59 0.84
50D Range: 0.34 0.84
200D Range: 0.34 1.23

Quarterly Earnings
Annual Earnings

Reported Date	EPSChange YoY	EstimateSurprise
Feb 14, 22	-0.11 Increased by +67.65%	-0.08 Decreased by -37.50%
Nov 16, 20	-0.01 Increased by +93.33%	-0.07 Increased by +85.71%
Aug 13, 20	-0.07 Increased by +68.18%	-0.08 Increased by +12.50%
Jun 29, 20	0.24 Increased by +442.86%	-0.12 Increased by +300.00%
Nov 13, 19	-0.34 Increased by +45.16%	-0.11 Decreased by -209.09%
Aug 14, 19	-0.15 Increased by +34.78%	-0.17 Increased by +11.76%
Jun 26, 19	-0.22 Decreased by -173.33%	-0.10 Decreased by -120.00%
Feb 14, 19	-0.07 Increased by +76.67%	-0.10 Increased by +30.00%

Quarterly Financials
Annual Financials

Fiscal ending date	RevenueChange YoY	IncomeChange YoY	ProfitChange YoY
Sep 30, 22	0.00 Decreased by N/A%	-4.93 M Decreased by -602.45%	Decreased by N/A% Decreased by N/A%
Jun 30, 22	0.00 Decreased by N/A%	-4.52 M Decreased by -45.09%	Decreased by N/A% Decreased by N/A%
Mar 31, 22	0.00 Decreased by -100.00%	-3.90 M Increased by +30.85%	Decreased by N/A% Decreased by N/A%
Dec 31, 21	0.00 Decreased by -100.00%	-3.78 M Decreased by -17.33%	Decreased by N/A% Decreased by N/A%
Sep 30, 21	0.00 Decreased by N/A%	981.00 K Increased by +115.96%	Increased by +N/A% Decreased by N/A%
Jun 30, 21	0.00 Decreased by N/A%	-3.12 M Increased by +33.18%	Decreased by N/A% Decreased by N/A%
Mar 31, 21	115.00 K Increased by +N/A%	-5.65 M Decreased by -132.78%	Decreased by -4.91 K% Decreased by N/A%
Dec 31, 20	81.00 K Increased by +N/A%	-3.22 M Increased by +73.26%	Decreased by -3.98 K% Decreased by N/A%

Top 20 ETF Stock Exposure
Top 20 Institutional Holders
Top 20 Mutual Fund Holders

Rank	ETF	Shares	Market Value	Weight % in ETF

DAILY

WEEKLY

MONTHLY

Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.